Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Wark

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
Journal of Psychosomatic Research|August 23, 2024
Prevalence of psychotropic medication dispensing to people living with cystic fibrosis in Australia: 2013-2022Louise Lord, Peter Wark, Mark Hew, et al.
Social Work in Health Care|April 15, 2022
Mental health care needs in cystic fibrosis: A scoping reviewCampbell Tickner, Lucy Holland, Peter Wark, et al.
ANZ Journal of Surgery|March 4, 2025
A 20-year case-series of distal intestinal obstruction syndrome at a state-wide cystic fibrosis serviceChen Lew, Chelsea Lin, Matthew Lukies, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 19, 2019
Lumacaftor/ivacaftor reduces exacerbations in adults homozygous for Phe508del mutation with severe lung diseaseKoliarne Tong, Daniel Barker, Megan France, et al.
ERJ Open Research|February 3, 2021
Avatar acceptability: views from the Australian Cystic Fibrosis community on the use of personalised organoid technology to guide treatment decisionsLaura K Fawcett, Claire E Wakefield, Sheila Sivam, et al.
ERJ Open Research|October 1, 2024
Real-world use of inhaled corticosteroid/formoterol as needed in adults with mild asthma: the PRIME studyGuy Brusselle, Francesco Blasi, Christian Gessner, et al.
International Journal of Chronic Obstructive Pulmonary Disease|June 4, 2024
Mapping the Common Barriers to Optimal COPD Care in High and Middle-Income Countries: Qualitative Perspectives from CliniciansOrjola Shahaj, Anne Meiwald, Krishnan Puri Sudhir, et al.
The European Respiratory Journal|June 21, 2023
Saline at lower tonicity in cystic fibrosis (SALTI-CF) trial comparing 0.9% <i>versus</i> 3% <i>versus</i> 6% nebulised salineTiffany J Dwyer, Mark R Elkins, Ruth Dentice, et al.
Trials|March 23, 2023
BEAT CF pulmonary exacerbations core protocol for evaluating the management of pulmonary exacerbations in people with cystic fibrosisAndre Schultz, Charlie McLeod, Scott Berry, et al.
Colloids and Surfaces. B, Biointerfaces|August 23, 2018
Assessing the potential of liposomes loaded with curcumin as a therapeutic intervention in asthmaZhao Yin Ng, Jin-Ying Wong, Jithendra Panneerselvam, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Journal of Psychosomatic Research|August 23, 2024
Prevalence of psychotropic medication dispensing to people living with cystic fibrosis in Australia: 2013-2022Louise Lord, Peter Wark, Mark Hew, et al.
Social Work in Health Care|April 15, 2022
Mental health care needs in cystic fibrosis: A scoping reviewCampbell Tickner, Lucy Holland, Peter Wark, et al.
ANZ Journal of Surgery|March 4, 2025
A 20-year case-series of distal intestinal obstruction syndrome at a state-wide cystic fibrosis serviceChen Lew, Chelsea Lin, Matthew Lukies, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 19, 2019
Lumacaftor/ivacaftor reduces exacerbations in adults homozygous for Phe508del mutation with severe lung diseaseKoliarne Tong, Daniel Barker, Megan France, et al.
ERJ Open Research|February 3, 2021
Avatar acceptability: views from the Australian Cystic Fibrosis community on the use of personalised organoid technology to guide treatment decisionsLaura K Fawcett, Claire E Wakefield, Sheila Sivam, et al.
ERJ Open Research|October 1, 2024
Real-world use of inhaled corticosteroid/formoterol as needed in adults with mild asthma: the PRIME studyGuy Brusselle, Francesco Blasi, Christian Gessner, et al.
International Journal of Chronic Obstructive Pulmonary Disease|June 4, 2024
Mapping the Common Barriers to Optimal COPD Care in High and Middle-Income Countries: Qualitative Perspectives from CliniciansOrjola Shahaj, Anne Meiwald, Krishnan Puri Sudhir, et al.
The European Respiratory Journal|June 21, 2023
Saline at lower tonicity in cystic fibrosis (SALTI-CF) trial comparing 0.9% <i>versus</i> 3% <i>versus</i> 6% nebulised salineTiffany J Dwyer, Mark R Elkins, Ruth Dentice, et al.
Trials|March 23, 2023
BEAT CF pulmonary exacerbations core protocol for evaluating the management of pulmonary exacerbations in people with cystic fibrosisAndre Schultz, Charlie McLeod, Scott Berry, et al.
Colloids and Surfaces. B, Biointerfaces|August 23, 2018
Assessing the potential of liposomes loaded with curcumin as a therapeutic intervention in asthmaZhao Yin Ng, Jin-Ying Wong, Jithendra Panneerselvam, et al.
Pageof 7